It is not the announcement we have been expecting:
biz.yahoo.com
Monday August 14, 8:30 am Eastern Time
Press Release
Coulter Pharmaceutical Announces $35.8 Million
Private Placement
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Aug. 14, 2000-- Coulter Pharmaceutical, Inc. (Nasdaq:CLTR -
news) today announced that it has entered into definitive purchase agreements for the sale of 1,655,000 shares of newly issued
common stock to selected institutional and other accredited investors for approximately $35.8 million. The purchase price was
$21.625 per share. The shares of common stock have not been registered under the Securities Act of 1933, as amended, and
may not be offered or sold in the United States absent registration, or an applicable exemption from registration. Pacific Growth
Equities, Inc. served as the placement agent for this transaction.
The Company intends to use net proceeds from this private placement to fund its commercialization efforts as well as its
research and development activities including additions to personnel, pre-clinical studies, clinical trials, and manufacturing.
etc. etc. |
